A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and <i>Neisseria meningitidis</i> outer membrane vesicles
Darielys Santana-Mederos, Rocmira Pérez-Nicado, Yanet Climent-Ruíz, Laura Rodríguez, Belinda Sánchez Ramírez, Sonia Pérez-Rodríguez, Meybi Rodriguez, Claudia Labrada, Tays Hernández, Marianniz Díaz-Hernández, Ivette Orosa, Ubel Ramírez, Reynaldo Oliva, Raine Garrido, Félix Cardoso, Mario Landys, Roselyn Martínez, Humberto González Galbán, Tamara Hernández, Rolando Ochoa-Azze, José L. Pérez, Juliet Enriquez, N Lastre González, Yenicet Infante, Luis Ariel Espinosa, Yassel Ramos, Luis Javier González, Carmen Valenzuela, Ana Victoria Casadesús, Briandy Fernández-Marrero, Gertrudis Rojas, Beatriz Pérez-Massón, Yaima Tundidor, Ernesto Cañarte Bermúdez, Claudia A. Plasencia, Tammy Boggiano-Ayo, Eduardo Ojito, Fabrizio Chiodo, Sonsire Fernández-Castillo, Françoise Paquet, Fang Cheng, Guang‐Wu Chen, Daniel G. Rivera, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Vérez-Bencomo
Abstract
Soberana01 is composed of the SARS-CoV-2 dimeric RBD and Neisseria meningitidis outer membrane vesicles (OMVs) adsorbed on alum. This vaccine induces a potent neutralizing immune response and shows potential against SARS-CoV-2 variants of concern.